RxDoctor Payments Data

Eddie Wu, DO

Adult Reconstructive Orthopaedic Surgery · Vineland, NJNPI 1215182332

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.9% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 74.9% of it on its own, with 10 other manufacturers making up the rest. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NJ, where the typical reported total is $8,051.

$8,134in general payments, 2019–2025

Across 117 payments — averaging $69.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Microport Orthopedics Inc$598
  • Hikma Pharmaceuticals USA$423
  • Zimmer Biomet$245
  • Davol Inc.$195
  • Johnson & Johnson$192
  • plus $393 from 5 others

What the payments were for

  • Consulting fees$4235%
  • Travel & lodging$481%
  • Food & beverage$7,55893%
  • Education$1051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,134 in reported general payments places this provider in the 50th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.

See all adult reconstructive orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$328,191
Medicare patients
589
Services billed
2,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium ErDiclofenac Sodium179$5,957
CeftriaxoneCeftriaxone Sodium14$291
Amoxicillin114$166
Doxycycline Hyclate29$159
Methylprednisolone28$155
Diclofenac Sodium14$115
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen25$114
Oxycodone Hcl28$95
Pregabalin22$91
Celecoxib17$91
Meloxicam29$80
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$77
Tramadol Hcl20$42
Naproxen11$40
Famotidine23$39

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Vineland

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →